[1] |
SHIPKOVA M, WIELAND E. Editorial: immune monitoring in solid organ transplantation[J]. Clin Biochem, 2016, 49(4/5): 317-319. DOI: 10.1016/j.clinbiochem.2016.01.005.
|
[2] |
YU M, LIU M, ZHANG W, et al. Pharmacokinetics, pharmacodynamics and pharmacogenetics of tacrolimus in kidney transplantation[J]. Curr Drug Metab, 2018, 19(6): 513-522. DOI: 10.2174/1389200219666180129151948.
|
[3] |
ZHUANG Q, PENG B, WEI W, et al. The detailed distribution of T cell subpopulations in immune-stable renal allograft recipients: a single center study[J]. PeerJ, 2019, 7: e6417. DOI: 10.7717/peerj.6417.
|
[4] |
CHAE MS, KIM JW, CHUNG HS, et al. The impact of serum cytokines in the development of early allograft dysfunction in living donor liver transplantation[J]. Medicine (Baltimore), 2018, 97(16): e0400. DOI: 10.1097/MD.0000000000010400.
|
[5] |
MARGETA I, MAREKOVIĆ I, PEŠUT A, et al. Evaluation of cell-mediated immune response by quantiFERON monitor assay in kidney transplant recipients presenting with infective complications[J]. Medicine (Baltimore), 2020, 99(27): e21010. DOI: 10.1097/MD.0000000000021010.
|
[6] |
LEE DM, ABECASSIS MM, FRIEDEWALD JJ, et al. Kidney graft surveillance biopsy utilization and trends: results from a survey of high-volume transplant centers[J]. Transplant Proc, 2020, 52(10): 3085-3089. DOI: 10.1016/j.transproceed.2020.04.1816.
|
[7] |
PLATTNER BW, CHEN P, CROSS R, et al. Complications and adequacy of transplant kidney biopsies: a comparison of techniques[J]. J Vasc Access, 2018, 19(3): 291-296. DOI: 10.1177/1129729817747543.
|
[8] |
ALSPACH E, LUSSIER DM, SCHREIBER RD. Interferon γ and its important roles in promoting and inhibiting spontaneous and therapeutic cancer immunity[J]. Cold Spring Harb Perspect Biol, 2019, 11(3): a028480. DOI: 10.1101/cshperspect.a028480.
|
[9] |
FARHOOD B, NAJAFI M, MORTEZAEE K. CD8+ cytotoxic T lymphocytes in cancer immunotherapy: a review[J]. J Cell Physiol, 2019, 234(6): 8509-8521. DOI: 10.1002/jcp.27782.
|
[10] |
SHIU KY, MCLAUGHLIN L, REBOLLO-MESA I, et al. Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell-dependent indirect antidonor alloresponses and autocrine regulation of interferon-γ production by Th1 cells[J]. Kidney Int, 2017, 91(2): 477-492. DOI: 10.1016/j.kint.2016.10.009.
|
[11] |
CRESPO E, CRAVEDI P, MARTORELL J, et al. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients[J]. Kidney Int, 2017, 92(1): 201-213. DOI: 10.1016/j.kint.2016.12.024.
|
[12] |
KIM T, LEE HJ, KIM SM, et al. Diagnostic usefulness of the cytomegalovirus (CMV)-specific T cell-based assay for predicting CMV infection after kidney transplant[J]. Korean J Intern Med, 2020, 35(2): 438-448. DOI: 10.3904/kjim.2017.318.
|
[13] |
KRISNAWATI DI, LIU YC, LEE YJ, et al. Blockade effects of anti-interferon- (IFN-) γ autoantibodies on IFN-γ-regulated antimicrobial immunity[J]. J Immunol Res, 2019: 1629258. DOI: 10.1155/2019/1629258.
|
[14] |
HOU H, ZHOU Y, YU J, et al. Establishment of the reference intervals of lymphocyte function in healthy adults based on IFN-γ secretion assay upon phorbol-12-myristate-13-acetate/ionomycin stimulation[J]. Front Immunol, 2018, 9: 172. DOI: 10.3389/fimmu.2018.00172.
|
[15] |
LUO Y, XIE Y, ZHANG W, et al. Combination of lymphocyte number and function in evaluating host immunity[J]. Aging (Albany NY), 2019, 11(24): 12685-12707. DOI: 10.18632/aging.102595.
|
[16] |
WIEBE C, KOSMOLIAPTSIS V, POCHINCO D, et al. HLA-DR/DQ molecular mismatch: a prognostic biomarker for primary alloimmunity[J]. Am J Transplant, 2019, 19(6): 1708-1719. DOI: 10.1111/ajt.15177.
|
[17] |
ISRAELI M, KLEIN T, BRANDHORST G, et al. Confronting the challenge: individualized immune monitoring after organ transplantation using the cellular immune function assay[J]. Clin Chim Acta, 2012, 413(17/18): 1374-1378. DOI: 10.1016/j.cca.2012.01.033.
|
[18] |
REZAHOSSEINI O, MØLLER DL, KNUDSEN AD, et al. Use of T cell mediated immune functional assays for adjustment of immunosuppressive or anti-infective agents in solid organ transplant recipients: a systematic review[J]. Front Immunol, 2020, 11: 567715. DOI: 10.3389/fimmu.2020.567715.
|
[19] |
HARTMANN FJ, BABDOR J, GHERARDINI PF, et al. Comprehensive immune monitoring of clinical trials to advance human immunotherapy[J]. Cell Rep, 2019, 28(3): 819-831. DOI: 10.1016/j.celrep.2019.06.049.
|
[20] |
PENG B, GONG H, TIAN H, et al. The study of the association between immune monitoring and pneumonia in kidney transplant recipients through machine learning models[J]. J Transl Med, 2020, 18(1): 370. DOI: 10.1186/s12967-020-02542-2.
|
[21] |
UDOMKARNJANANUN S, KERR SJ, TOWNAMCHAI N, et al. Donor-specific ELISPOT assay for predicting acute rejection and allograft function after kidney transplantation: a systematic review and Meta-analysis[J]. Clin Biochem, 2021, 94: 1-11. DOI: 10.1016/j.clinbiochem.2021.04.011.
|
[22] |
毛天赐, 田普训, 薛武军, 等. 分泌干扰素-γ的效应T细胞在预警肾移植术后急性排斥反应中的意义[J]. 器官移植, 2013, 4(6): 325-330. DOI: 10.3969/j.issn.1674-7445.2013.06.004.MAO TC, TIAN PX, XUE WJ, et al. Significance of effector T cell secreting interferon-γ on early warning of acute rejection after renal transplantation[J]. Organ Transplant, 2013, 4(6): 325-330. DOI: 10.3969/j.issn.1674-7445.2013.06.004.
|
[23] |
SALDAN A, FORNER G, MENGOLI C, et al. Comparison of the cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV quantiFERON cell-mediated immune assays in CMV-seropositive and -seronegative pregnant and nonpregnant women[J]. J Clin Microbiol, 2016, 54(5): 1352-1356. DOI: 10.1128/JCM.03128-15.
|
[24] |
ATLANI M, SHARMA RK, GUPTA A. Basiliximab induction in renal transplantation: long-term outcome[J]. Saudi J Kidney Dis Transpl, 2013, 24(3): 473-479. DOI: 10.4103/1319-2442.111010.
|
[25] |
HOU X, LU C, CHEN S, et al. High throughput sequencing of T cell antigen receptors reveals a conserved TCR repertoire[J]. Medicine (Baltimore), 2016, 95(10): e2839. DOI: 10.1097/MD.0000000000002839.
|
[26] |
GILL RG, BURRACK AL. Diverse routes of allograft tolerance disruption by memory T cells[J]. Front Immunol, 2020, 11: 580483. DOI: 10.3389/fimmu.2020.580483.
|
[27] |
LEE SJ, KIM HJ, BYUN NR, et al. Donor-specific regulatory T cell-mediated immune tolerance in an intrahepatic murine allogeneic islet transplantation model with short-term anti-CD154 mAb single treatment[J]. Cell Transplant, 2020, 29: 963689720913876. DOI: 10.1177/0963689720913876.
|
[28] |
PATHAK S, MEYER EH. Tregs and mixed chimerism as approaches for tolerance induction in islet transplantation[J]. Front Immunol, 2021, 11: 612737. DOI: 10.3389/fimmu.2020.612737.
|
[29] |
HIGDON LE, TROFE-CLARK J, LIU S, et al. Cytomegalovirus-responsive CD8+ T cells expand after solid organ transplantation in the absence of CMV disease[J]. Am J Transplant, 2017, 17(8): 2045-2054. DOI: 10.1111/ajt.14227.
|
[30] |
BETJES MGH, LANGERAK AW, KLEPPER M, et al. A very low thymus function identifies patients with substantial increased risk for long-term mortality after kidney transplantation[J]. Immun Ageing, 2020, 17: 4. DOI: 10.1186/s12979-020-00175-z.
|
[31] |
CHEN D, ZHAO R, CAO W, et al. Clinical characteristics of cytomegalovirus gastritis: a retrospective study from a tertiary medical center[J]. Medicine (Baltimore), 2020, 99(5): e18927. DOI: 10.1097/MD.0000000000018927.
|
[32] |
FERREIRA VH, KUMAR D, HUMAR A. Deep profiling of the CD8+ T-cell compartment identifies activated cell subsets and multifunctional responses associated with control of cytomegalovirus viremia[J]. Transplantation, 2019, 103(3): 613-621. DOI: 10.1097/TP.0000000000002373.
|
[33] |
DENDLE C, MULLEY WR, HOLDSWORTH S. Can immune biomarkers predict infections in solid organ transplant recipients? a review of current evidence[J]. Transplant Rev (Orlando), 2019, 33(2): 87-98. DOI: 10.1016/j.trre.2018.10.001.
|
[34] |
DRABE CH, SØRENSEN SS, RASMUSSEN A, et al. Immune function as predictor of infectious complications and clinical outcome in patients undergoing solid organ transplantation (the ImmuneMo: SOT study): a prospective non-interventional observational trial[J]. BMC Infect Dis, 2019, 19(1): 573. DOI: 10.1186/s12879-019-4207-9.
|